Cancer combination therapy of the sesquiterpenoid artesunate and the selective EGFR-tyrosine kinase inhibitor erlotinib

Authors

Keywords

Cancer, Natural products, Small molecule inhibitors, Synergy

Journal

Volume 37, Issue -, Pages 58-61

Publisher

Elsevier BV

Online

2017-11-10

DOI

10.1016/j.phymed.2017.11.003

Contact the author

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now